0001140361-18-014256.txt : 20180320 0001140361-18-014256.hdr.sgml : 20180320 20180320141631 ACCESSION NUMBER: 0001140361-18-014256 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180315 FILED AS OF DATE: 20180320 DATE AS OF CHANGE: 20180320 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BIENAIME JEAN JACQUES CENTRAL INDEX KEY: 0001221590 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26727 FILM NUMBER: 18701517 MAIL ADDRESS: STREET 1: 925 PAGE MILL ROAD CITY: PALO ALTO STATE: CA ZIP: 94304 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC CENTRAL INDEX KEY: 0001048477 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 680397820 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 BUSINESS PHONE: 4155066700 MAIL ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 4 1 doc1.xml FORM 4 X0306 4 2018-03-15 0 0001048477 BIOMARIN PHARMACEUTICAL INC BMRN 0001221590 BIENAIME JEAN JACQUES C/O BIOMARIN PHARMACEUTICAL INC. 770 LINDARO ST. SAN RAFAEL CA 94901 1 1 0 0 Chief Executive Officer Common Stock 2018-03-15 2018-03-15 4 M 0 15000 38.59 A 279674 D Common Stock 2018-03-15 2018-03-15 4 S 0 15000 84.7267 D 264674 D Common Stock 2018-03-15 2018-03-15 4 F 0 14908 83.57 D 249766 D Common Stock 2018-03-15 2018-03-15 4 A 0 46340 0 A 296106 D Common Stock 182201 I Shares held by Jean-Jacques Bienaime Family Trust Stock Option (Right to buy Common Stock) 38.59 2018-03-15 2018-03-15 4 M 0 15000 38.59 A 2008-11-22 2018-05-21 Common Stock 15000 157500 D Stock Option (Right to buy Common Stock) 83.57 2018-03-15 2018-03-15 4 A 0 148190 0 A 2019-03-15 2028-03-14 Common Stock 148190 148190 D This transaction, originally due to be reported on Monday, March 19, 2018, is being reported late due to an administrative oversight. Trade made pursuant to a 10b5-1 plan executed on November 14, 2017. The price in column 4 is the weighted average price. The price actually received ranged from $84.26 to $85.91. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price. Restricted stock units granted on March 15, 2018. Price not applicable. Option grant vests 12/48th on March 15, 2019 and 1/48th on the 15th day of each month thereafter. /s/ Laura Randall Woodhead, Attorney-in-Fact 2018-03-20